• SR-202: Selective PPARγ Antagonist for Insulin Resistance Re

  2026-06-29

  SR-202 ((S)-(4-chlorophenyl)(dimethoxyphosphoryl)methyl dimethyl phosphate) is a selective PPARγ antagonist with demonstrated efficacy in inhibiting PPAR-dependent adipocyte differentiation and improving insulin sensitivity in preclinical models. Its specificity and solubility profile make it an essential tool for obesity and type 2 diabetes research.

• Qushi Huoxue Ointment Ameliorates MASLD via Autophagy and Fe

  2026-06-29

  This study demonstrates that Qushi Huoxue ointment (QSHXO) significantly reduces hepatic lipid accumulation and inflammation in metabolic associated steatotic liver disease (MASLD) models by activating autophagy and inhibiting ferroptosis. These mechanistic insights clarify how coordinated modulation of cellular pathways may inform future MASLD interventions.

• Intraperitoneal mRNA-LNP Programming of CAR Macrophages in C

  2026-06-28

  This study introduces a macrophage-targeted mRNA lipid nanoparticle (LNP) system for direct intraperitoneal programming of chimeric antigen receptor (CAR) macrophages, enabling tailored anti-tumor immunity against solid tumor metastases. The approach systematically explores CAR design and demonstrates robust remodeling of the tumor microenvironment, highlighting new directions for cancer immunotherapy.

• Phalloidin (B7678): Technical Guidance for F-Actin Visualiza

  2026-06-27

  Phalloidin (SKU B7678) is a cyclic heptapeptide toxin used to achieve stable, high-affinity labeling and preservation of filamentous actin (F-actin) in fixed or permeabilized cells. This product addresses the need for reliable cytoskeleton visualization in static biological samples, but it is not suitable for live-cell imaging or assays requiring reversible actin dynamics.

• BAPTA-AM: Protocols and Best Practices for Calcium Chelation

  2026-06-26

  BAPTA-AM is a cell-permeable calcium chelator designed for precise regulation of intracellular Ca²⁺ in live cell assays, facilitating studies of calcium signaling, apoptosis, and neuroprotection. It is best used where selective, rapid intracellular calcium buffering is critical, but is not suitable for applications requiring water solubility or magnesium-selective chelation.

• Calpeptin as a Calpain Inhibitor: Bridging Cell Death Pathwa

  2026-06-26

  Explore how Calpeptin, a potent calpain inhibitor, uniquely advances fibrosis and inflammation studies by targeting regulated cell death pathways. This article delivers a mechanistic deep-dive and practical guidance for researchers seeking to leverage Calpeptin’s specificity and reliability in experimental design.

• Selective IRAP Inhibition: Bestatin-Derived Nanomolar Inhibi

  2026-06-25

  This study introduces highly selective, nanomolar inhibitors of insulin-regulated aminopeptidase (IRAP) based on α-hydroxy-β-amino acid derivatives of Bestatin. The work provides structural and mechanistic insights into inhibitor design, with implications for targeted aminopeptidase regulation in cancer and immunology research.

• Bacillus Strains and Media Shape γ-Glutamyl Peptide Producti

  2026-06-25

  This study systematically investigates how different Bacillus strains and growth media modulate the production of γ-glutamyl peptides, particularly di- and tripeptides, with implications for kokumi taste enhancement and glutathione pathway research. The findings highlight the critical roles of substrate selection and microbial metabolism, providing actionable insights for researchers in food biotechnology and peptide biochemistry.

• QX77: Advanced Mechanistic Insights for Autophagy and Stem C

  2026-06-24

  Discover how QX77, a molecular chaperone activator, uniquely enables precise autophagy pathway modulation and stem cell differentiation studies. This deep-dive article explores mechanisms, protocol optimization, and actionable insights beyond existing resources.

• Dimethyloxalylglycine (DMOG): Technical Guide & Protocol Par

  2026-06-23

  Dimethyloxalylglycine (DMOG) enables researchers to model hypoxia-induced cellular responses by stabilizing hypoxia-inducible factors through competitive inhibition of prolyl-4-hydroxylase domain enzymes in vitro and in vivo. It is not intended for diagnostic or clinical use and requires strict adherence to technical protocols for reliable results.

• Comparative Antibacterial Activities of Cefoperazone and MK0

  2026-06-23

  Cullmann et al. systematically compared the in vitro antibacterial activities of N-formimidoyl thienamycin (MK0787) and several recently developed β-lactam antibiotics, including cefoperazone, against a diverse panel of resistant bacterial clinical isolates. Their findings clarify the nuanced activity profiles and β-lactamase stability of these agents, providing a robust foundation for future research on gram-negative resistance and assay optimization.

• AICAR and AMPK: Strategic Insights for Translational Researc

  2026-06-22

  AMPK activation by AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) offers a mechanistic bridge between cellular energetics and inflammation control. This article provides translational researchers with a synthesis of mechanistic evidence, protocol guidance, and strategic context for deploying AICAR in metabolic and immunoinflammatory studies, with a focus on obesity-related asthma and beyond.

• BMS-345541: Unraveling Angiogenesis and Inflammation via IKK

  2026-06-22

  Explore how BMS-345541, a potent IKK-1/IKK-2 inhibitor, enables advanced inflammation and angiogenesis research by dissecting Notch/NF-κB pathway dynamics. Discover new experimental insights and assay guidance beyond standard protocols.

• Monomeric Amyloid Beta Regulates Microglia in Brain Developm

  2026-06-21

  Kwon et al. (2024) reveal a previously unrecognized signaling pathway in which monomeric amyloid beta-peptide (Aβ) inhibits microglial activation during mouse neocortical development. This finding expands the physiological roles of Aβ, suggesting that depletion of its monomeric form may contribute to neurodevelopmental disruption and Alzheimer's disease pathology.

• Functional Genomic Screens Clarify Drug-Induced Cell Death M

  2026-06-20

  Honeywell et al. introduce MEDUSA, a simulation-assisted approach that disentangles growth and death rates in functional genomic screens to reveal how drugs induce cell death. This method exposes key regulators of both apoptotic and non-apoptotic lethality, improving precision in mapping drug action and informing therapeutic strategy.

466 records 14/32 page Previous Next First page 上5页 1112131415 下5页 Last page